Cordlife Group Limited Stock

Equities

P8A

SG2E64980112

Healthcare Facilities & Services

Market Closed - Singapore S.E. 04:59:25 2024-05-15 am EDT 5-day change 1st Jan Change
0.13 SGD +1.56% Intraday chart for Cordlife Group Limited +3.17% -58.73%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2021 56.67M 41.98M Sales 2022 55.16M 40.86M Capitalization 81.91M 60.68M
Net income 2021 6M 4.44M Net income 2022 4M 2.96M EV / Sales 2021 0.71 x
Net cash position 2021 61.98M 45.92M Net cash position 2022 63.75M 47.23M EV / Sales 2022 0.33 x
P/E ratio 2021
16.7 x
P/E ratio 2022
16.8 x
Employees 538
Yield 2021
2.25%
Yield 2022
-
Free-Float 31.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.47%
1 week+7.14%
Current month+8.00%
1 month-7.53%
3 months-51.79%
6 months-70.00%
Current year-57.14%
More quotes
1 week
0.12
Extreme 0.123
0.14
1 month
0.12
Extreme 0.118
0.15
Current year
0.12
Extreme 0.118
0.32
1 year
0.12
Extreme 0.118
0.57
3 years
0.12
Extreme 0.118
0.57
5 years
0.12
Extreme 0.118
0.63
10 years
0.12
Extreme 0.118
1.72
More quotes
Managers TitleAgeSince
Director of Finance/CFO 48 11-05-31
Chief Operating Officer - 13-02-28
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 68 18-05-21
Chairman 52 11-06-15
Director/Board Member 52 19-12-11
More insiders
Date Price Change Volume
24-05-15 0.13 +1.56% 101 000
24-05-13 0.128 +1.59% 298,200
24-05-10 0.126 0.00% 49,900
24-05-09 0.126 0.00% 50,000
24-05-08 0.126 +5.00% 3,100

Delayed Quote Singapore S.E., May 15, 2024 at 01:49 am EDT

More quotes
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Company’s segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW